Last updated 2026-07-26
- Raised $10M Series D led by Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Apr 2024
- Raised $13.6M Series C led by Peregrine Ventures, Nov 2022
- Raised $5.4M Series B led by Cancer Focus Fund, Feb 2022
Total raised
$36.0M
Last: Undisclosed Round 2024-05
Stage
Series A
Founded
2017
Headcount
11
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Nectin Therapeutics is a clinical-stage biotechnology company focused on transforming the lives of cancer patients by developing next-generation immune-oncology (IO) and antibody-drug conjugate (ADC) therapies. The company's therapies aim to overcome resistance to existing IO treatments by leveraging unique insights into the nectin pathways. Nectin Therapeutics was established in 2017 based on research conducted at the Hebrew University of Jerusalem and the University of Rijeka. Their technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies and antibody-drug-conjugates. The company has offices in Jerusalem, Israel, and Fort Lee, New Jersey, USA.
Funding history · 6 rounds · $36.0M total
2024-04
D Round
$10.0M
★ Guangzhou Sino-Israel Biotech Investment Fund (GIBF)
2023-04
C Round Extension
Undisclosed
★ Myeloma Investment Fund
2022-11
C Round
$13.6M
★ Peregrine Ventures★ Israel Biotech FundaMoon Fund
2022-02
B Round
$5.4M
★ Cancer Focus Fund
2020-06
A Round
$6.0M
★ aMoon FundIntegra Holdings
2016-12
Seed
$1.0M
★ Integra Holdings
Headcount over time
From 9 (2022-03) to 11 (2025-10) · +2 (+22%) · 6 points · source: Finder history + radar grounding
Q&A
- What is Nectin Therapeutics' primary focus?
- Nectin Therapeutics is a clinical-stage biotechnology company focused on developing next-generation immune-oncology (IO) and antibody-drug conjugate (ADC) therapies for cancer patients.
- When was Nectin Therapeutics founded?
- Nectin Therapeutics was established in 2017 based on research conducted at the Hebrew University of Jerusalem and the University of Rijeka.
- How many employees does Nectin Therapeutics currently have?
- Nectin Therapeutics has 11-50 employees.
- What was Nectin Therapeutics' most recent funding round?
- In May 2024, Nectin Therapeutics raised $10,000,000 in an A Round, with.
- Which investors participated in Nectin Therapeutics' Series A funding round in November 2022?
- In November 2022, Nectin Therapeutics raised $25,000,000 in an A Round, with IBF.
- What was the amount of the grant received by Nectin Therapeutics in August 2024?
- In August 2024, Nectin Therapeutics received a grant of $2,699,999.
- Who are the co-founders of Nectin Therapeutics?
- The co-founders of Nectin Therapeutics are Ofer Mandelboim and Pini Tsukerman.
- What is the status of Nectin Therapeutics' product development?
- Nectin Therapeutics' products are in the clinical trial stage.
- What was Nectin Therapeutics' collaboration with Merck announced in February 2023?
- In February 2023, Nectin Therapeutics announced a collaboration with Merck on a clinical trial of their anti-PVR antibody NTX1088 in combination with KEYTRUDA® (pembrolizumab) for patients with locally advanced and metastatic solid tumors.
Team · 11
Ofer Mandelboim
Founder · Co-founder
Pini Tsukerman
Founder · Co-founder & CSO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
biotechnologypharmaceuticalsoncologyimmunologycancer-therapycancerantibodiespatientsdrug-deliverytreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nectintx.com |
|---|---|
| linkedin.com/company/69206104 |
Identifiers & details
| Legal name | Nectin Therapeutics Ltd. |
|---|---|
| Founded | 2017 |
| Employees (exact) | 11 |
| Offices | Fort Lee |
Radar intelligence
Patents
| EPO | 6 |
|---|
Web history (Wayback)
| Domain | nectintx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515675890 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-06-19 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | פארק ההי-טק קמפוס גבעת רם - ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |